| BIOGEN INC. DL -,0005 | 268.80 / -0.37% |
| Date/Time | 02/07 / 15:00 |
| Chg. / Chg.(%) | -1.00 / -0.37% |
| Bid | 268.75 / 40 |
| Ask | 269.90 / 60 |
| Open | 266.60 |
| Previous Close | 269.80 |
| High | 268.80 |
| Low | 266.60 |
| Volume [EUR] | 0.00 |
| Volume [Units] | 0 |
| Price fixings | 8 |
| ISIN | US09062X1037 |
| Security | IDP |
| Exchange | Düsseldorf |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| TradeGate | 268.950 |  |
52 |
| Xetra | 270.00 | |
35 |
| gettex | 269.750 | |
3 |
| Vienna Globa.. | 268.90 | |
0 |
| München | 266.65 |  |
0 |
| Hamburg | 266.65 | |
0 |
| Düsseldorf | 268.80 | |
0 |
| Berlin | 269.65 | |
0 |
| Frankfurt | 266.8500 | |
0 |
| Hannover | 266.65 |  |
0 |
| Quotrix | 268.6500 | |
|
| Lang & Schwa.. | 268.800 | |
|
| Stuttgart | 266.700 | |
|
| NASDAQ | 288.2800 | |
782,811 |
| IEX | 288.43 | |
52,689 |
| Cboe US | 288.19 | 38,752 | |
| London Domes.. | 290.94 | 1,223 |
News
- FDA approves drug for early Alzheimer's treatment
01/06/2023 / 21:10 - TeleTrader - Wall Street extends losses on rate talks, China unrest
11/28/2022 / 19:15 - TeleTrader - Biogen falls 5% after death in Alzheimer's drug trial
11/28/2022 / 13:40 - TeleTrader - Biogen's EPS sees annual jump of 253% in Q3
10/25/2022 / 13:05 - TeleTrader - Biogen's Q2 EPS soar by 142.14% to $7.24 per share
07/20/2022 / 13:01 - TeleTrader
Real-time